Open Angle Glaucoma Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Growing Demand for Oral Drugs
   3. Market Restraints
      1. Limited Patient Awareness and Diagnosis
      2. High Treatment Costs and Limited Access
   4. Market Opportunities
      1. Increasing Occurrence of Blindness Cases
   5. Market Trends
      1. Increasing Emphasis on Minimally Invasive Glaucoma Surgeries (MIGS)
      2. Integration of Artificial Intelligence (AI) in Glaucoma Diagnosis and Management
5. MARKET SEGMENTATION
   1. By Type
      1. Closed Angle Glaucoma (CAG)
      2. Open Angle Glaucoma (OAG)
      3. Secondary Glaucoma
      4. Congenital Glaucoma
      5. Others
   2. By Drug Class
      1. Beta Blockers
      2. Prostaglandins
      3. Alpha Adrenergic Agonist
      4. Carbonic Anhydrase Inhibitors
      5. Combination Drugs
      6. Others
   3. By End User
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
   4. By Distribution Channel
      1. Hospital Pharmacy
      2. Online Pharmacy
      3. Retail Pharmacy
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Aerie Pharmaceuticals, Inc. (U.S.)
      2. Amorphex Therapeutics Holdings, Inc (U.S.)
      3. Abbvie, Inc (U.S.)
      4. Accutome,Inc (U.S.)
      5. AqueSys (U.S.)
      6. Alcon (Switzerland)
      7. Astellas Pharma Inc. (Japan)
      8. Bayer AG (Germany)
      9. Bausch Health Companies Inc (Canada)
      10. Carl Zeiss Meditec AG (Germany)
      11. EyePointPharmaceuticals,Inc (U.S.)
      12. Fera Pharmaceuticals (U.S.)
      13. Iridex Corporation (U.S.)
      14. Kubota Vision Inc (U.S.)
      15. Merck & Co. Inc. (U.S.)
      16. Novartis AG (U.S.)
      17. Nidek Co Ltd (India)
      18. Pfizer Inc. (U.S.)
      19. Teva Pharmaceutical Industries Ltd. (Israel)

b. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Open Angle Glaucomamarket?

The global market of Open Angle Glaucoma is projected to reach USD 7.99 Mn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Open Angle Glaucomamarket?

The global Open Angle Glaucoma market has an estimated annual growth rate of 4.0%.

Q.3. What are the recent trends of Open Angle Glaucomamarket?

Increasing emphasis on minimally invasive glaucoma surgeries (MIGS) and integration of artificial intelligence (AI) in glaucoma diagnosis and management are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Open Angle Glaucoma?

The major companies profiled in this report include Aerie Pharmaceuticals, Inc. (U.S.), Amorphex Therapeutics Holdings, Inc (U.S.), Abbvie, Inc (U.S.), Accutome,Inc (U.S.), AqueSys (U.S.), Alcon (Switzerland), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Bausch Health Companies Inc (Canada), Carl Zeiss Meditec AG (Germany), EyePointPharmaceuticals,Inc (U.S.), Fera Pharmaceuticals (U.S.), Iridex Corporation (U.S.), Kubota Vision Inc (U.S.), Merck & Co. Inc. (U.S.), Novartis AG (U.S.), Nidek Co Ltd (India), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), among others.

Q.5. Which region is estimated to held highest CAGR inOpen Angle Glaucomamarket?

North America is estimated to hold biggest share in the market for Open Angle Glaucoma.